ENDOGENOUS ENDOPHTHALMITIS IN THE SETTING OF COVID-19 INFECTION: A Case Series. Issue 8 (August 2021)
- Record Type:
- Journal Article
- Title:
- ENDOGENOUS ENDOPHTHALMITIS IN THE SETTING OF COVID-19 INFECTION: A Case Series. Issue 8 (August 2021)
- Main Title:
- ENDOGENOUS ENDOPHTHALMITIS IN THE SETTING OF COVID-19 INFECTION
- Authors:
- Bilgic, Alper
Sudhalkar, Aditya
Gonzalez-Cortes, Jesus H.
March de Ribot, Francesc
Yogi, Rohit
Kodjikian, Laurent
Mathis, Thibaud - Abstract:
- Abstract : Purpose: To describe endogenous endophthalmitis in the setting of COVID-19 pneumonia. Methods: Patients recovering from COVID-19 pneumonia who presented to our department with any or all of the following complaints: pain, watering, redness, and decreased vision were identified. All relevant data were collected for analysis. Results: Three patients with endogenous endophthalmitis were identified. All patients had been treated for COVID-19 pneumonia and therefore had received remdesivir and systemic steroids; 2 of the 3 patients received tocilizumab. All patients received vitreous biopsy, vitrectomy, and intraocular antibiotic injection. Patient 1 demonstrated Klebsiella pneumoniae in blood culture, K. pneumoniae and Escherichia coli in urine culture, and K. pneumoniae in vitreous fluid, whereas Patients 2 and 3 demonstrated Stenotrophomonas maltophilia and methicillin-resistant Staphylococcus aureus in the blood and nasopharyngeal culture, respectively. Correspondingly, the same organism was cultured from vitreous in Patients 2 and 3. The visual acuity at the last follow-up in Patients 1 to 3 was 20/100, 20/80, and 20/40, respectively. The probable source of infection was identified in each as renal calculi, dental caries, and the pharynx, respectively. Real-time polymerase chain reaction demonstrated the presence of Severe Acute Respiratory Syndrome Coronavirus 2 in the vitreous fluid of Patient 1. Conclusion: We report good outcomes of early intervention forAbstract : Purpose: To describe endogenous endophthalmitis in the setting of COVID-19 pneumonia. Methods: Patients recovering from COVID-19 pneumonia who presented to our department with any or all of the following complaints: pain, watering, redness, and decreased vision were identified. All relevant data were collected for analysis. Results: Three patients with endogenous endophthalmitis were identified. All patients had been treated for COVID-19 pneumonia and therefore had received remdesivir and systemic steroids; 2 of the 3 patients received tocilizumab. All patients received vitreous biopsy, vitrectomy, and intraocular antibiotic injection. Patient 1 demonstrated Klebsiella pneumoniae in blood culture, K. pneumoniae and Escherichia coli in urine culture, and K. pneumoniae in vitreous fluid, whereas Patients 2 and 3 demonstrated Stenotrophomonas maltophilia and methicillin-resistant Staphylococcus aureus in the blood and nasopharyngeal culture, respectively. Correspondingly, the same organism was cultured from vitreous in Patients 2 and 3. The visual acuity at the last follow-up in Patients 1 to 3 was 20/100, 20/80, and 20/40, respectively. The probable source of infection was identified in each as renal calculi, dental caries, and the pharynx, respectively. Real-time polymerase chain reaction demonstrated the presence of Severe Acute Respiratory Syndrome Coronavirus 2 in the vitreous fluid of Patient 1. Conclusion: We report good outcomes of early intervention for endogenous endophthalmitis in the setting of COVID-19 infection. We also document the presence of SARS-CoV-2 in vitreous. Abstract : This short case series looks at whether the SARS-CoV-2 can be detected in vitreous fluid and the outcomes of endogenous endophthalmitis in patients receiving care for COVID-19 infection. … (more)
- Is Part Of:
- Retina. Volume 41:Issue 8(2021)
- Journal:
- Retina
- Issue:
- Volume 41:Issue 8(2021)
- Issue Display:
- Volume 41, Issue 8 (2021)
- Year:
- 2021
- Volume:
- 41
- Issue:
- 8
- Issue Sort Value:
- 2021-0041-0008-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-08
- Subjects:
- COVID-19 -- SARS-CoV-2 -- endophthalmitis -- endogenous -- tocilizumab -- steroids
Retina -- Diseases -- Periodicals
Retinal Diseases
Vitreous Body
617.735 - Journal URLs:
- http://journals.lww.com/retinajournal/pages/default.aspx ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/IAE.0000000000003168 ↗
- Languages:
- English
- ISSNs:
- 0275-004X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 7785.510300
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18923.xml